Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment?

Changing insights regarding radioiodine (I-131) administration in differentiated thyroid carcinoma (DTC) stir up discussions on the utility of pre-ablation diagnostic scintigraphy (DxWBS). Our retrospective study qualitatively and semi-quantitatively assessed posttherapy I-131 whole-body scintigraph...

Descripción completa

Detalles Bibliográficos
Autores principales: de Koster, Elizabeth J., Sulaiman, Taban, Hamming, Jaap F., Schepers, Abbey, Snel, Marieke, van Velden, Floris H. P., de Geus-Oei, Lioe-Fee, Vriens, Dennis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003652/
https://www.ncbi.nlm.nih.gov/pubmed/33808843
http://dx.doi.org/10.3390/diagnostics11030553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003652/
https://www.ncbi.nlm.nih.gov/pubmed/33808843
http://dx.doi.org/10.3390/diagnostics11030553

Ejemplares similares